MacroGenics Presents Pre-Clinical Data on Inhibition of Autoimmune Diseases With DART Candidate MGD010 at IMMUNOLOGY 2014

[GlobeNewswire] – ROCKVILLE, Md. — MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and identifying innovative monoclonal antibody-based therapeutics for the treatment of cancer and … more

View todays social media effects on MGNX

View the latest stocks trending across Twitter. Click to view dashboard

See who MacroGenics is hiring next, click here to view